Premium
Traws Pharma Inc (TRAW)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, pr... Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. Show more
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu PR Newswire NEWTOWN, Pa...
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program PR Newswire SAN DIEGO, Jan. 10, 2025 SAN DIEGO, Jan. 10, 2025 /PRNewswire/ -- Expert Systems, a hybrid AI...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.54 | 7.08661417323 | 7.62 | 8.23 | 6.96 | 38966 | 7.36616211 | CS |
| 4 | -0.725 | -8.15981992122 | 8.885 | 9.31 | 5.44 | 103049 | 7.10014224 | CS |
| 12 | 2.35 | 40.4475043029 | 5.81 | 19.44 | 4.06 | 620429 | 11.95540846 | CS |
| 26 | -0.84 | -9.33333333333 | 9 | 19.44 | 4.06 | 303317 | 11.47935967 | CS |
| 52 | -16.59 | -67.0303030303 | 24.75 | 24.75 | 4.06 | 223283 | 12.16156753 | CS |
| 156 | -16.59 | -67.0303030303 | 24.75 | 24.75 | 4.06 | 223283 | 12.16156753 | CS |
| 260 | -16.59 | -67.0303030303 | 24.75 | 24.75 | 4.06 | 223283 | 12.16156753 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
